FAS and rheumatoid arthritis: ARG098, a novel anti-Fas/APO-1/CD95 monoclonal antibody, exhibits potency for treating RA synovial hyperplasia, which plays crucial roles in joint destruction in RA patients, by decreasing the numbers of RA synoviocytes and synovium-infiltrating lymphocytes via Fas-mediated apoptosis.